Advance Therapy Revenue and Competitors
Estimated Revenue & Valuation
- Advance Therapy's estimated annual revenue is currently $8.6M per year.
- Advance Therapy's estimated revenue per employee is $233,514
Employee Data
- Advance Therapy has 37 Employees.
- Advance Therapy grew their employee count by 19% last year.
Advance Therapy's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Speech-Language Pathologist - CF | Reveal Email/Phone |
Advance Therapy Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $363.6M | 703 | -6% | N/A | N/A |
#2 | $4.9M | 26 | -4% | N/A | N/A |
#3 | $16.3M | 67 | -4% | N/A | N/A |
#4 | $45.7M | 141 | 18% | N/A | N/A |
#5 | $22.4M | 66 | 3% | N/A | N/A |
#6 | $108.3M | 265 | 6% | N/A | N/A |
#7 | $128.9M | 306 | 3% | N/A | N/A |
#8 | $20.5M | 53 | -10% | N/A | N/A |
#9 | $762.2M | 1978 | 4% | $1.1B | N/A |
#10 | $1690M | 1133 | 26% | N/A | N/A |
What Is Advance Therapy?
Advance Therapy is a hospital & health care company based out of 1415 E Colorado St # 212, Glendale, California, United States.
keywords:N/A
N/A
Total Funding
37
Number of Employees
$8.6M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Advance Therapy News
2022-04-20 - Coeptis Combines with Bull Horn in SPAC Deal to Advance ...
CD38-GEAR-NK is a natural killer (NK) cell- based therapy candidate that supports combination treatment with anti-CD38 monoclonal antibodies (...
2022-04-19 - Novel CAR T Therapy for Solid Tumors: 'Exciting Advance'
Now, a new CAR T construct that targets the tumor-specific antigen claudin 6 (CLDN6) is showing promising preliminary activity against relapsed...
2022-04-13 - Cell therapy biotech raises $120M to advance therapy to treat common cornea
condition
Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that affects millions of people.
Other Companies in Glendale
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.4M | 37 | 3% | N/A |
#2 | $10.4M | 37 | 6% | N/A |
#3 | $7.4M | 37 | 3% | N/A |
#4 | $10.2M | 37 | 6% | N/A |
#5 | $35M | 37 | 42% | N/A |